Lower baseline cerebrospinal fluid amyloid-β 42 is associated with amyloid-related imaging abnormalities during real-world lecanemab treatment.
- DOI
- 10.1177/13872877261488874
- Published
- 2026-09-15
- Container
- J Alzheimers Dis
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/13872877261488874,
title = {Lower baseline cerebrospinal fluid amyloid-β 42 is associated with amyloid-related imaging abnormalities during real-world lecanemab treatment.},
author = {Takahashi R and Kashibayashi T and Fujita J and Yoshida K and Hashiramoto A and Kowa H and Mizuta E.},
year = {2026},
journal = {J Alzheimers Dis},
doi = {10.1177/13872877261488874},
url = {https://doi.org/10.1177/13872877261488874}
}RIS
TY - JOUR TI - Lower baseline cerebrospinal fluid amyloid-β 42 is associated with amyloid-related imaging abnormalities during real-world lecanemab treatment. AU - Takahashi R AU - Kashibayashi T AU - Fujita J AU - Yoshida K AU - Hashiramoto A AU - Kowa H AU - Mizuta E. PY - 2026 JO - J Alzheimers Dis DO - 10.1177/13872877261488874 UR - https://doi.org/10.1177/13872877261488874 ER -
APA
R, T., T, K., J, F., K, Y., A, H., H, K., & E., M. (2026). Lower baseline cerebrospinal fluid amyloid-β 42 is associated with amyloid-related imaging abnormalities during real-world lecanemab treatment.. J Alzheimers Dis. https://doi.org/10.1177/13872877261488874
Source records
- europe-pmc · retrieved 2026-09-27T05:01:58.893Z